We are live on ! Find out more
IMVT icon

Immunovant
IMVT

133 hedge funds and large institutions have $980M invested in Immunovant in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,504% more call options, than puts

Call options by funds: $8.87M | Put options by funds: $246K

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

312% more capital invested

Capital invested by funds: $238M → $980M (+$742M)

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

89% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 28

19% more funds holding

Funds holding: 112 → 133 (+21)

7.16% more ownership

Funds ownership: 36.59% → 43.75% (+7.2%)

Holders
133
Holders Change
+21
Holders Change %
+18.75%
% of All Funds
2.14%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.08%
New
39
Increased
53
Reduced
28
Closed
18
Calls
$8.87M
Puts
$246K
Net Calls
+$8.62M
Net Calls Change
+$6.06M

Top Buyers

1
LGM
Logos Global Management
California
+$39.7M
2
BI
BVF Inc
California
+$32.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.3M
4
State Street
State Street
Massachusetts
+$28.1M
5
CAC
Cowen and Company
New York
+$15.7M

Top Sellers

1
AGM
Alpine Global Management
New York
-$35.9M
2
EAM
Eventide Asset Management
Massachusetts
-$21.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.3M
4
WP
Woodline Partners
California
-$11.9M
5
OCA
Octagon Capital Advisors
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
$172M -$1.89M -150,246 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$90M +$13.5M +1,068,669 +27%
BlackRock
3
BlackRock
New York
$69.7M +$5.32M +422,750 +12%
EAM
4
Eventide Asset Management
Massachusetts
$65.6M -$21.1M -1,678,792 -31%
LGM
5
Logos Global Management
California
$55.9M +$39.7M +3,150,000 New
State Street
6
State Street
Massachusetts
$55.3M +$28.1M +2,234,342 +254%
BI
7
BVF Inc
California
$45.5M +$32.2M +2,561,000 New
Fidelity Investments
8
Fidelity Investments
Massachusetts
$44.2M +$31.3M +2,487,410 +344,040%
AGM
9
Alpine Global Management
New York
$26.6M -$35.9M -2,848,017 -66%
CAC
10
Cowen and Company
New York
$22.2M +$15.7M +1,250,000 New
CC
11
Commodore Capital
New York
$20.4M +$14.5M +1,150,505 New
RG
12
Redmile Group
California
$19.3M +$13.7M +1,088,131 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$17.8M +$2.39M +189,926 +23%
Citadel Advisors
14
Citadel Advisors
Florida
$17.3M +$11.4M +901,589 +1,267%
IC
15
Ikarian Capital
Texas
$17.2M +$1.95M +155,000 +19%
TCM
16
TCG Crossover Management
California
$15.2M +$10.8M +854,853 New
WP
17
Woodline Partners
California
$14.5M -$11.9M -947,331 -54%
FLSM
18
Frazier Life Sciences Management
California
$10.4M – – –
Walleye Capital
19
Walleye Capital
New York
$9.48M +$4.61M +366,270 +219%
PAMP
20
Polar Asset Management Partners
Ontario, Canada
$9.37M +$6.65M +528,000 New
SCM
21
Silverarc Capital Management
Massachusetts
$9.22M +$2.77M +219,614 +73%
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$7.73M -$19.3M -1,531,549 -78%
Northern Trust
23
Northern Trust
Illinois
$7.42M +$857K +68,068 +19%
PIM
24
Platinum Investment Management
Australia
$7.3M -$3.12M -247,778 -38%
CAM
25
Cormorant Asset Management
Massachusetts
$7.1M +$5.04M +400,000 New
1
2 3 4 5

IMVT Hedge Fund Activity: Q4 2022 in Review

133 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q4 2022, worth a combined $980M — up 312% from $238M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IMVT positions and 18 closed out — a net gain of 21 holders — while 53 added to existing stakes and 28 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $39.7M. The largest seller was Alpine Global Management, cutting an estimated $35.9M.

  • 133 institutional investors held Immunovant (IMVT) as of Q4 2022, up from 112 in Q3 2022.
  • Funds reported $980M of Immunovant stock for Q4 2022, up 312% quarter-over-quarter.
  • 39 funds opened new Immunovant positions in Q4 2022 and 18 closed out, a net change of +21 holders.
  • The largest Immunovant buyer in Q4 2022 was Logos Global Management, an estimated $39.7M added.
  • The largest Immunovant seller in Q4 2022 was Alpine Global Management, an estimated $35.9M sold.

Based on aggregated 13F filings for Q4 2022.